Buprenorphine is a critical part of treatment for the growing epidemic of opioid abuse—but also carries the potential for misuse and diversion. The debate over whether 'to expand or not to expand' ...
People addicted to prescription painkillers reduce their opioid abuse when given sustained treatment with the medication buprenorphine plus naloxone (Suboxone), according to research published in ...
SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- The buprenophine in the Suboxone will combine with opioid receptors to give a person the same feeling as if they were on such drugs as heroin. The reason ...
Cropped portrait, hand holding Suboxone pill, two people holding hands. If a person with opioid use disorder overdoses and survives, that person can either seek help or continue using. When the person ...
Experts said Buprenorphine is prescribed to manage severe pain after surgeries, cancer-related pain and opioid addiction by ...
Twenty-four percent of US adolescent treatment centers do not use a “lifesaving” medication. An article appeared today in the Journal of the American Medical Association titled “Treatments Used Among ...
When Daniel Patrick Garrett began using Suboxone three years ago, he spent hours driving to find a pharmacy that would accept his prescription for the opioid use disorder treatment. Eight couldn't or ...
Buprenorphine is a treatment medication that decreases mortality risks among people with opioid use disorder (OUD). Despite its efficacy, buprenorphine is underused in the US. Insurance restrictions ...
In 2020, Indivior resolved the federal government's long-running probe into its aggressive marketing of the opioid addiction therapy Suboxone, reaching a $600 million plea deal. Now, it's paying up.
Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of ...
Buprenorphine, an important drug in fighting the opioid crisis, has long been closely monitored over concerns it would be abused. But a first-of-its-kind government oversight report released Thursday ...
Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder. Objectives: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results